Resqunit

Strategic Integration and Future Plans

RESQUNIT AB (PUBL) is actively working on integrating and adapting to the investment operations from Bio Vitos into its core business. The company’s strategic direction will focus on acquiring and managing equity positions in health and life sciences companies across key financial markets in Europe, including Nasdaq Sweden and the London Stock Exchange.

To provide clarity on the implementation of this acquisition and the future business operations, RESQUNIT AB (PUBL) plans to publish further details shortly. This will include concrete acquisition proposasl that will be presented in a notice to an upcoming extraordinary general meeting. The notice will outline the specifics of the new business activities as well as the terms of a planned rights issue.
As part of this strategic update, RESQUNIT AB (PUBL) reiterates the key terms of the acquisition from Bio Vitos, which involve the purchase of the investment operations and associated assets. This acquisition is being financed through the issuance of new shares, representing 29.9 percent of RESQUNIT AB’s expanded share capital.

Availability of Business Description Document

The detailed business description document attached to this press release is also available for download on RESQUNIT AB (PUBL)’s official website. Investors and stakeholders are encouraged to review the document for a comprehensive understanding of the company’s vision, strategy, and operational focus.

Next Steps

RESQUNIT AB (PUBL) will continue to focus on its new core operations and strategic initiatives while ensuring transparency with its shareholders and stakeholders. The company remains committed to delivering value through strategic investments in the health and life sciences sectors.